 |
Stroke Weekly News: 726 headlines |
|
|||||||||||||
A pregnant mother..a baby..faith of a husband.. .plus... Cardiac Standstill: cooling the patient to 15 degrees Centigrade!| Executive Editor..Anne Merete Robbs CEO..............Stan Swartz |
||||
 |
||||
|
||||
| 4 TALES OF NEUROSURGERY & A PIANO CONCERT BY DR. SPETZLER... Plus 2 books written by Survivors for Survivors! |
||||
 |
||||
| Robert F. Spetzler M.D. Director, Barrow Neurological Institute J.N. Harber Chairman of Neurological Surgery Professor Section of Neurosurgery University of Arizona |
||||
| TALES OF NEUROSURGERY: | ||||
A pregnant mother..a baby..faith of a husband.. .plus... Cardiac Standstill: cooling the patient to 15 degrees Centigrade! |
||||
| Lou Grubb Anurism |
||||
| The young Heros - kids who are confronted with significant medical problems! |
||||
| 2 Patients...confronted with enormous decisions before their surgery...wrote these books to help others! |
||||
| A 1 MINUTE PIANO CONCERT BY DR. SPETZLER |
||||
| Sources used by our Heart & Stroke News Research Team: | ||||
| The New York Times, CNN, FOX, CBS, BBC, Mayo Clinic, Johns Hopkins Medicine, UCLA Medical Center, National Institute of Health, Stanford Hospital, Memorial Sloan- Kettering, Yale Cancer Center, Massachusetts General Hospital, Brigham and Women's Hospital, University of Michigan, M. D. Anderson Cancer Center, National Institute of Health, American Cancer Association, NBC, Reuters News, American College of Cardiology, Journal of the American Medical Association & 100's more | ||||
| Links | ||||
|
||||
| Archives | ||||
| January 2005 | ||||
| February 2005 | ||||
| March 2005 | ||||
| April 2005 | ||||
| May 2005 | ||||
| June 2005 | ||||
| July 2005 | ||||
| August 2005 | ||||
| September 2005 | ||||
| October 2005 | ||||
| November 2005 | ||||
| December 2005 | ||||
| January 2006 | ||||
| February 2006 | ||||
| March 2006 | ||||
| April 2006 | ||||
| May 2006 | ||||
| June 2006 | ||||
| July 2006 | ||||
| August 2006 | ||||
| September 2006 | ||||
| October 2006 | ||||
| November 2006 | ||||
| December 2006 | ||||
| January 2007 | ||||
| February 2007 | ||||
| March 2007 | ||||
| June 2007 | ||||
| April 2008 | ||||
| May 2008 | ||||
| January 2009 | ||||
| January 2014 |
Wednesday
CAMPATH: NEWS MS DRUG WITH GREAT POTENTIAL
Phase III MS study planned
...The companies are also pressing on with plans to start a Phase III study of Campath for the treatment of relapsing/remitting multiple sclerosis, although this strategy has run into difficulties of late. They were forced to halt dosing in a Phase II trial of Campath for MS after a patient died of a serious bleeding disorder.
However, the drug's efficacy was seen to be excellent, cutting the relapse rate in patients by 75% compared to the comparator drug, Serono's blockbuster Rebif (interferon beta-1a).
Furthermore, Campath is given just once a year, while Rebif is administered three times a week, providing another significant treatment advantage.CLICK FOR FULL STORY
Phase III MS study planned
...The companies are also pressing on with plans to start a Phase III study of Campath for the treatment of relapsing/remitting multiple sclerosis, although this strategy has run into difficulties of late. They were forced to halt dosing in a Phase II trial of Campath for MS after a patient died of a serious bleeding disorder.
However, the drug's efficacy was seen to be excellent, cutting the relapse rate in patients by 75% compared to the comparator drug, Serono's blockbuster Rebif (interferon beta-1a).
Furthermore, Campath is given just once a year, while Rebif is administered three times a week, providing another significant treatment advantage.CLICK FOR FULL STORY